静脉溶栓治疗发病7～12h脑梗死患者27例临床分析  

Clinical Analysis on Venous Thrombolytic Therapy in 27 Cerebral Infarction Patients at 7 to 12 Hours

作　　者：盖红[1] 魏学昱[1] 韩丽荣[1] 

机构地区：[1]山东省博兴县人民医院,山东博兴256500

出　　处：《中国现代医生》2008年第22期63-64,共2页China Modern Doctor

摘　　要：目的研究发病7～12h脑梗死患者溶栓治疗的安全性及有效性。方法通过对发病7～12h和发病小于6h脑梗死患者溶栓治疗对比,对发病7～12h脑梗死患者溶栓和非溶栓治疗组疗效对比。结果6h内溶栓治疗组有效率80.5%,无效11%,加重8.3%7～12h溶栓治疗组有效率61.1%,无效16.6%,加重22.2%。一般治疗组有效率19.2%,无效率23%,恶化30.7%。结论发病7～12h脑梗死患者溶栓治疗安全有效值得推广。Objective To research the security and the effect of venous thrombolytic therapy in 27 cerebral infarction patients in pathogenesis of 7 to 12 hours. Methods The thromholytic therapy between patients in pathogenesis of 7 to 12 hours and those within 6 hours,the effect between thronholytic therapy and common therapy in infarction patients in pathogenesis of 7 to 12 hours were compared. Results In the thrombolytic therapy group within 6 hours,the effective rate was 80.5% ,invalid rate was 11%,worsen rate was 8.3%,in the group 7 to 12 hours,the effective rate was 61.1%,uneffective rate was 16.6%,worsen rate was 22.2%,common therapy group,the effective rate was 19.2%,uneffective rate was 23%,worsen rate was 30.7%. Conclusion Thronbolytic therapy is secure and effective in infarction patients in pathogenesis of 7 to 12 hours and it is worthy to be extended.

关 键 词：急性脑梗死 尿激酶 溶栓治疗 

分 类 号：R743.33[医药卫生—神经病学与精神病学]